Relief Therapeutics Holding SA / Key words: Study results
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023
22March2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA / Key words: Study results
Relief Therapeutics to Present PreClinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting
17March2023 / 22:45 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this a... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA
/ Key words: Market Launch
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe
16.03.2023 / 07:00 CET/CEST
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs® in Europe
The Company also discloses it has transferred most o... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA / Key words: Market Launch
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™
15March2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Therapeutics Pro... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA
/ Key words: Market Launch
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars
28.02.2023 / 07:00 CET/CEST
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE® Bars
Paol... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA / Key words: Study
Relief Therapeutics Announces Enrollment of First Three Patients in ProofofConcept Clinical Trial of RLFTD011 for the Treatment of Epidermolysis Bullosa
14Feb2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.... Lire le communiqué |
|
|
|
|
Relief Therapeutics Holding SA / Key words: Financing
Relief Therapeutics Provides an Update on its Financing Strategy
08Feb2023 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.
Relief Therapeutics Provides an Update on its Financing Strategy... Lire le communiqué |
|
|
|
|